Top Business Stories from the U.S.
Updated: 2 hours 37 min ago
U.S. crude closed higher Friday but was still down on the week. Some pros expect the slide to continue.
Obama will sign an executive order on Friday to enhance credit and debit security.
Though deadlier than many infectious diseases, the odds of dying from Ebola in the US are still extremely low.
Appointing an Ebola czar was more of a marketing gimmick but will likely have a calming effect on the market, says Michael Yoshikami.
In a new report, business travelers rate Italian chain Olive Garden most highly.
A federal bankruptcy court judge voided a union contract with Atlantic City's Trump Taj Mahal Casino Resort on Friday.
Short-only portfolio manager Brad Lamensdorf expects stocks to bounce.
U.S. officials have asked three advanced biology laboratories to submit plans for producing the experimental Ebola drug ZMapp.
Fifteen percent of advisors specialize in niches but account for a third of advisor assets. A look at five niche practice areas.
Despite a series of negative headlines, the NRF on Friday stood by its forecast for 4.1 percent growth.
"I think with today's rally, there is some magnetic pull that we should expect," one market veteran tells CNBC.
Despite its oil revenues, Venezuela's economic and fiscal situations are in free fall. Learn why here.
Politicians are jumping on the Ebola bandwagon as a campaign tactic, but will it sway the midterm elections?
A new study shows millennial job turnover is less than a third of the tenure among people aged 55 to 64 years old.
An Atlanta-area school district will not admit new students from the West African countries with medical documentation and superintendent approval.
OTC Markets will resume trading operations at 1 p.m. ET Friday after a temporary halt from Finra.
Russia and Ukraine agreed to a deal for gas supplies for the winter period.
Mortgage credit may rise and lenders may be protected from charges of making bad loans if a deal goes through, The WSJ reported.
One big takeaway may have been lost: Every U.S. Ebola patient has been treated with at least one investigational product.
If you think wealth inequality in the U.S. is bad, consider Russia.